Salivary Biomarkers

Diseases are often discovered in an advanced stage because of the lack of specific symptoms and the difficulties in diagnosis. The more advanced the stage of diseases, the more invasive the diagnostic and treatment interventions needed. Therefore, an early molecular diagnosis is of vital importance to increase the survival rate. A good diagnostic method should have the characteristics of high sensitivity, specificity, and functionality and meet the requirements of high throughput, portability, and low cost for subsequent clinical application. Early detection of disease plays a crucial role in successful therapy. Today, the improved efficiency and accuracy of biomarker discovery technologies are turning Salivary Diagnostics into a clinical reality.Saliva-based diagnostics is on the cutting edge of diagnostic technology and may offer a robust alternative for clinicians to use in the near future to make clinical decisions and predict post-treatment outcomes.